Dermatology Medical News about Psoriasis

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
Medicare Final Rule for 2010

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients
Dermatology, 10/26/09

Khosrotehrani K et al. – A personal history of atopic symptoms is predictive of eczema under infliximab. Specific information should be provided to atopic patients starting such a treatment.

Exclusive Author Commentary
Kiarash Khosrotehrani, 10/26/09

Many patients under anti-TNF therapy require dermatological advice for different disorders and in my practice, eczema has appeared as the main reason. We therefore sought to establish a relationship with preexisting atopy and other parameters. A personal history of atopy seems predictive of eczema in patients under infliximab.

<< Previous
Acceleration of permeability barrier recovery by exposure of skin...

Next >>
Smart drugs for cognitive enhancement: ethical and pragmatic...